City National Bank’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

City National Bank’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-31,400	Closed	-$373K	–	934
2014 Q1	$373K	Hold	31,400	–	–	0.01%	611
2013 Q4	$434K	Buy	+31,400	New	+$443K	0.01%	593

Other funds holding INFI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

City National Bank's INFI Position: Q2 2014 in Review

City National Bank sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2014, closing a stake of 31,400 shares — an estimated $373K sold.

City National Bank first reported a position in INFI in Q4 2013 and held it in 2 quarters. The position peaked at $434K in Q4 2013. 98 funds tracked by Wall St. Rank hold INFI as of Q2 2014.

City National Bank reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
City National Bank sold 31,400 Infinity Pharmaceuticals, Inc. shares in Q2 2014, an estimated $373K.
City National Bank first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2013 and held it in 2 quarters.
City National Bank's Infinity Pharmaceuticals, Inc. position peaked at $434K in Q4 2013.
98 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2014.

Based on City National Bank's 13F filing for Q2 2014, filed 28 Jul 2014.